The recent challenges in global chains have highlighted the necessity of securing critical medications like Ivermectin. Dependence on overseas manufacturers exposes countries to significant vulnerabilities, including https://haimapltk330869.slypage.com/39385999/protecting-this-medication-acquisition-national-production